Movie
Controller
Structure viewers
About EMN search
-Search query
-Search result
Showing 1 - 50 of 312 items for (author: burton & no)
EMDB-63444: 
Zebrafish ovum lysosomal peptide:N-glycanase
Method: single particle / : Honda A, Kamada K, Burton-Smith RN, Murata K, Suzuki T
PDB-9lwg:
Zebrafish ovum lysosomal peptide:N-glycanase
Method: single particle / : Honda A, Kamada K, Burton-Smith RN, Murata K, Suzuki T
EMDB-48548:
SARS-CoV-2 S2 monomer in complex with R125-61 Fab
Method: single particle / : Park S, Bangaru B, Ward AB
EMDB-48549:
SARS-CoV-2 S2 monomer in complex with NICA01B-1113 Fab
Method: single particle / : Park S, Bangaru B, Ward AB
EMDB-48550:
SARS-CoV-2 S2 monomer in complex with NICA01A-1401 Fab
Method: single particle / : Park S, Bangaru B, Ward AB
PDB-9mr1:
SARS-CoV-2 S2 monomer in complex with R125-61 Fab
Method: single particle / : Park S, Bangaru B, Ward AB
PDB-9mr2:
SARS-CoV-2 S2 monomer in complex with NICA01A-1401 Fab
Method: single particle / : Park S, Bangaru B, Ward AB
EMDB-45139:
nsEM map of macaque 32647 week 6 polyclonal Fab in complex with BG505 v5.2 Prime immunogen
Method: single particle / : Pratap PP, Cottrell CA, Ward AB
EMDB-45102:
nsEM map of macaque 32653 week 42 polyclonal Fab in complex with BG505 v5.2 Boost #2 immunogen
Method: single particle / : Pratap PP, Cottrell CA, Ward AB
EMDB-45140:
nsEM map of macaque 32653 week 6 polyclonal Fab in complex with BG505 v5.2 Prime immunogen
Method: single particle / : Pratap PP, Cottrell CA, Ward AB
EMDB-45141:
nsEM map of macaque 32647 week 10 polyclonal Fab in complex with BG505 v5.2 Boost #2 immunogen
Method: single particle / : Pratap PP, Cottrell CA, Ward AB
EMDB-45142:
nsEM map of macaque 32653 week 10 polyclonal Fab in complex with BG505 v5.2 Prime immunogen
Method: single particle / : Pratap PP, Cottrell CA, Ward AB
EMDB-45143:
nsEM map of macaque 32647 week 14 polyclonal Fab in complex with BG505 v5.2 Boost #2 immunogen
Method: single particle / : Pratap PP, Cottrell CA, Ward AB
EMDB-45144:
nsEM map of macaque 32653 week 14 polyclonal Fab in complex with BG505 v5.2 Prime immunogen
Method: single particle / : Pratap PP, Cottrell CA, Ward AB
EMDB-45145:
nsEM map of macaque 32647 week 18 polyclonal Fab in complex with BG505 v5.2 Boost #2 immunogen
Method: single particle / : Pratap PP, Cottrell CA, Ward AB
EMDB-45146:
nsEM map of macaque 32653 week 18 polyclonal Fab in complex with BG505 v5.2 Boost #2 immunogen
Method: single particle / : Pratap PP, Cottrell CA, Ward AB
EMDB-45147:
nsEM map of macaque 32647 week 22 polyclonal Fab in complex with BG505 v5.2 Boost #2 immunogen
Method: single particle / : Pratap PP, Cottrell CA, Ward AB
EMDB-45148:
nsEM map of macaque 32653 week 22 polyclonal Fab in complex with BG505 v5.2 Boost #2 immunogen
Method: single particle / : Pratap PP, Cottrell CA, Ward AB
EMDB-45149:
nsEM map of macaque 32653 week 26 polyclonal Fab in complex with BG505 v5.2 Boost #2 immunogen
Method: single particle / : Pratap PP, Cottrell CA, Ward AB
EMDB-40981:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody FP3
Method: single particle / : Pratap PP, Antansijevic A, Ozorowski G, Ward AB
EMDB-40982:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody N289
Method: single particle / : Pratap PP, Antansijevic A, Ozorowski G, Ward AB
PDB-8t2e:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody FP3
Method: single particle / : Pratap PP, Antansijevic A, Ozorowski G, Ward AB
PDB-8t2f:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody N289
Method: single particle / : Pratap PP, Antansijevic A, Ozorowski G, Ward AB
EMDB-40822:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody IF1
Method: single particle / : Pratap PP, Antansijevic A, Ozorowski G, Ward AB
EMDB-40823:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody IF3
Method: single particle / : Pratap PP, Antansijevic A, Ward AB
EMDB-40824:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody Base4
Method: single particle / : Pratap PP, Antansijevic A, Ward AB
PDB-8swv:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody IF1
Method: single particle / : Pratap PP, Antansijevic A, Ozorowski G, Ward AB
PDB-8sww:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody IF3
Method: single particle / : Pratap PP, Antansijevic A, Ward AB
PDB-8swx:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody Base4
Method: single particle / : Pratap PP, Antansijevic A, Ward AB
EMDB-40242:
BG505 MD39 SOSIP in complex with Rh.NJ85 wk12 gp120GH, N611/FP, and base epitope polyclonal antibodies
Method: single particle / : Lee WH, Ozorowski G, Torres JL, Ward AB
EMDB-40243:
BG505 MD39 SOSIP in complex with Rh.NJ86 wk12 V1V3, C3V5, N611/FP, and base epitope polyclonal antibodies
Method: single particle / : Lee WH, Ozorowski G, Torres JL, Ward AB
EMDB-40244:
BG505 MD39 SOSIP in complex with Rh.NJ76 wk12 C3V5, N611/FP, and base epitope polyclonal antibodies
Method: single particle / : Lee WH, Ozorowski G, Torres JL, Ward AB
EMDB-40252:
BG505 MD39 SOSIP in complex with Rh.NK04 wk12 gp120 glycan hole and base epitope polyclonal antibodies
Method: single particle / : Lee WS, Ozorowski G, Torres JL, Ward AB
EMDB-40254:
BG505 MD39 SOSIP in complex with Rh.NJ75 wk12 gp120 glycan hole and base epitope polyclonal antibodies
Method: single particle / : Lee WS, Ozorowski G, Torres JL, Ward AB
EMDB-40255:
BG505 MD39 SOSIP in complex with Rh.NJ87 wk12 C3V5 and base epitope polyclonal antibodies
Method: single particle / : Lee WS, Ozorowski G, Torres JL, Ward AB
EMDB-40256:
BG505 MD39 SOSIP in complex with Rh.NJ84 wk12 V1V3, gp120 glycan hole and base epitope polyclonal antibodies
Method: single particle / : Lee WS, Ozorowski G, Torres JL, Ward AB
EMDB-40257:
BG505 MD39 SOSIP in complex with Rh.NJ77 wk12 V1V3, C3V5, N611/FP and base epitope polyclonal
Method: single particle / : Lee WS, Ozorowski G, Torres JL, Ward AB
EMDB-40803:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody FP2
Method: single particle / : Pratap PP, Antansijevic A, Ward AB
EMDB-40804:
BG505 Boost2 SOSIP.664 in complex with NHP Polyclonal Antibody FP4
Method: single particle / : Pratap PP, Antansijevic A, Ward AB
EMDB-40805:
BG505 Boost 2 in complex with NHP antibody V1V2
Method: single particle / : Pratap PP, Antansijevic A, Ward AB
EMDB-40806:
BG505 Boost 2 in complex with NHP Polyclonal Antibody N625
Method: single particle / : Pratap PP, Antansijevic A, Ward AB
EMDB-40807:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody Base1
Method: single particle / : Pratap PP, Antansijevic A, Ward AB
EMDB-40808:
Boost 2 SOSIP.664 in complex with NHP polyclonal antibody Base2
Method: single particle / : Pratap PP, Antansijevic A, Ward AB
EMDB-40809:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody Base3
Method: single particle / : Pratap PP, Antansijevic A, Ward AB
EMDB-40810:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody FP1
Method: single particle / : Pratap PP, Antansijevic A, Ozorowski G, Ward AB
PDB-8sw7:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody FP1
Method: single particle / : Pratap PP, Antansijevic A, Ozorowski G, Ward AB
EMDB-34139:
E. hirae V-ATPase state 1 (whole complex)
Method: single particle / : Burton Smith RN, Murata K
EMDB-34140:
E. hirae V-ATPase state 1' (whole complex)
Method: single particle / : Burton Smith RN, Murata K
EMDB-34141:
E. hirae V-ATPase state 2 (whole complex)
Method: single particle / : Burton Smith RN, Murata K
EMDB-34142:
E. hirae V-ATPase state 2' (whole complex)
Method: single particle / : Burton Smith RN, Murata K
Pages:
wwPDB to switch to version 3 of the EMDB data model
